BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

898 related articles for article (PubMed ID: 17002034)

  • 1. Hemolytic uremic syndrome: an emerging health risk.
    Razzaq S
    Am Fam Physician; 2006 Sep; 74(6):991-6. PubMed ID: 17002034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome in Argentina].
    Rivero MA; Padola NL; Etcheverría AI; Parma AE
    Medicina (B Aires); 2004; 64(4):352-6. PubMed ID: 15338982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Child care-associated outbreak of Escherichia coli O157:H7 and hemolytic uremic syndrome.
    Raffaelli RM; Paladini M; Hanson H; Kornstein L; Agasan A; Slavinski S; Weiss D; Fennelly GJ; Flynn JT
    Pediatr Infect Dis J; 2007 Oct; 26(10):951-3. PubMed ID: 17901803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli.
    Johnson KE; Thorpe CM; Sears CL
    Clin Infect Dis; 2006 Dec; 43(12):1587-95. PubMed ID: 17109294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolytic uremic syndrome associated with Escherichia coli O157:H7 infection in older adults: a case report and review of the literature.
    Ko H; Maymani H; Rojas-Hernandez C
    J Med Case Rep; 2016 Jun; 10():175. PubMed ID: 27301547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shiga toxin-associated hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: distinct mechanisms of pathogenesis.
    Tarr PI
    Kidney Int Suppl; 2009 Feb; (112):S29-32. PubMed ID: 19180128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemolytic uremic syndrome caused by enterohaemorrhagic Escherichia coli].
    Ibarra C; Goldstein J; Silberstein C; Zotta E; Belardo M; Repetto HA
    Arch Argent Pediatr; 2008 Oct; 106(5):435-42. PubMed ID: 19030644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Post-diarrheal haemolytic uremic syndrome: when shall we consider it? Which follow-up?].
    Bertholet-Thomas A; Ranchin B; King LA; Bacchetta J; Belot A; Gillet Y; Collardeau-Frachon S; Cochat P
    Arch Pediatr; 2011 Jul; 18(7):823-30. PubMed ID: 21571510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study.
    Gerber A; Karch H; Allerberger F; Verweyen HM; Zimmerhackl LB
    J Infect Dis; 2002 Aug; 186(4):493-500. PubMed ID: 12195376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome similar to septic shock.
    Valles PG; Pesle S; Piovano L; Davila E; Peralta M; Principi I; Lo Giudice P
    Medicina (B Aires); 2005; 65(5):395-401. PubMed ID: 16296634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escherichia coli O157:H7 as the predominant pathogen associated with the hemolytic uremic syndrome: a prospective study in the Pacific Northwest.
    Neill MA; Tarr PI; Clausen CR; Christie DL; Hickman RO
    Pediatrics; 1987 Jul; 80(1):37-40. PubMed ID: 3299236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of hemolytic uremic syndrome].
    Nathanson S
    Arch Pediatr; 2007 May; 14(5):501-3. PubMed ID: 17442553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemolytic uremic syndrome in children of Mendoza, Argentina: association with Shiga toxin-producing Escherichia coli infection].
    Rivas M; Balbi L; Miliwebsky ES; García B; Tous MI; Leardini NA; Prieto MA; Chillemi GM; de Principi ME
    Medicina (B Aires); 1998; 58(1):1-7. PubMed ID: 9674201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome].
    Allerberger F; Sölder B; Caprioli A; Karch H
    Wien Klin Wochenschr; 1997 Sep; 109(17):669-77. PubMed ID: 9381722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enterohemorrhagic Escherichia coli--infection and a hemolytic uremic syndrome].
    Helminen M; Wisakanto KL; Raisio M; Baer M
    Duodecim; 1998; 114(3):229-32. PubMed ID: 10895492
    [No Abstract]   [Full Text] [Related]  

  • 17. Enterohemorrhagic Escherichia coli O157:H7--an emerging pathogen.
    Koutkia P; Mylonakis E; Flanigan T
    Am Fam Physician; 1997 Sep; 56(3):853-6, 859-61. PubMed ID: 9301577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Shiga-toxin-producing Escherichia coli in hemorrhagic colitis and hemolytic uremic syndrome.
    Cleary TG
    Semin Pediatr Infect Dis; 2004 Oct; 15(4):260-5. PubMed ID: 15494950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolytic uremic syndrome without hemolytic anemia: a case report.
    Akashi Y; Yoshizawa N; Oshima S; Takeuchi A; Kubota T; Kondo S; Oda T; Shimizu J; Ishida A; Nakabayashi I
    Clin Nephrol; 1994 Aug; 42(2):90-4. PubMed ID: 7955584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemolytic uremic syndrome: pathogenesis and update of interventions.
    Palermo MS; Exeni RA; Fernández GC
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):697-707. PubMed ID: 19681698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.